SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-18 Cr | ₹83 Cr | ₹-45 Cr | ₹-27 Cr | ₹-18 Cr |
What is the latest Cash Flow from Investing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-18 Cr |
| Mar2024 | ₹83 Cr |
| Mar2023 | ₹-45 Cr |
| Mar2022 | ₹-27 Cr |
| Mar2017 | ₹-18 Cr |
How is Cash Flow from Investing Activities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-18 Cr | Negative | |
| Mar2024 | ₹83 Cr | Positive | |
| Mar2023 | ₹-45 Cr | Negative | |
| Mar2022 | ₹-27 Cr | Negative | |
| Mar2017 | ₹-18 Cr | - | |
Compare Cash Flow from Investing Activities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,364.9 Cr | -3.3% | -9.2% | -33.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -3.3% |
-9.2% |
-33.1% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses